Mutabilis joins the European ENABLE consortium to fight antibiotic resistance

October 17, 2017
Mutabilis SAS

Biocitech, Paris, France, October 17, 2017 – Mutabilis, a company specialized in the discovery of new therapeutic approaches to treat resistant bacterial infections, today announces its selection by the European ENABLE project (European Gram-negative Antibacterial Engine), which aims to improve the development of antibiotics against infections caused by multiresistant Gram-negative bacteria. 

Download communique.